SHR-A1811 Injection

A1811 · Tongji Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-A1811 Injection, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer [Phase 1, Phase 2]